Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Liraglutide by Novo Nordisk for Pouchitis: Likelihood of Approval
Liraglutide is under clinical development by Novo Nordisk and currently in Phase II for Pouchitis. According to GlobalData, Phase II...